Long-Lasting Remission in De Novo Breast Myeloid Sarcoma Treated with Decitabine and Radiotherapy

Myeloid sarcoma (MS) represents a rare disease with an adverse clinical outcome for patients not candidate to acute myeloid leukemia (AML)-like chemotherapies. Here we present the case of an elderly patient affected by a bilateral breast localization of MS treated with the hypomethylating agent deci...

Descripción completa

Detalles Bibliográficos
Autores principales: Minoia, Carla, de Fazio, Vincenza, Scognamillo, Giovanni, Scattone, Anna, Maggialetti, Nicola, Ferrari, Cristina, Guarini, Attilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787642/
https://www.ncbi.nlm.nih.gov/pubmed/31357576
http://dx.doi.org/10.3390/diagnostics9030084
Descripción
Sumario:Myeloid sarcoma (MS) represents a rare disease with an adverse clinical outcome for patients not candidate to acute myeloid leukemia (AML)-like chemotherapies. Here we present the case of an elderly patient affected by a bilateral breast localization of MS treated with the hypomethylating agent decitabine associated to radiotherapy. The association of the two treatment modalities has allowed an optimal and long-lasting disease control.

Ejemplares similares